BiomeSense
Point-of-care biosensor for daily, automated human gut microbiome sampling and analysis11-50 EmployeesActively Hiring
BiomeSense Funding
$6.2M
11 round
BiomeSense is active in the following markets / industries: biotechnology, diagnostics and Microfluidic Automation. The company has secured funding across 1 rounds, totaling in an amount of $6.2M. Their most recent funding was raised on August 12, 2025.
Funding Rounds
S
$6178594